3D Printed Dosage Forms With Voxel-Based Drug Release Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing additive manufacturing processes for pharmaceutical dosage forms and medical devices lack flexibility in choosing base materials and active ingredient distribution, limiting the ability to create complex dosage forms with controlled release profiles and drug targeting.

Innovation Solution

A method involving the creation of three-dimensional objects through predefined volume increments, where each increment contains a base composition and can include pharmaceutical active ingredients, with varying volumes and compositions, allowing for layer-by-layer construction and controlled release profiles by adjusting the volume increments' sizes and arrangements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If traditional additive manufacturing processes are used for pharmaceutical dosage forms, then manufacturing capability is achieved, but flexibility in choosing base materials and active ingredient distribution is limited

Engineering Contradiction:
Improveflexibility in choosing base materials and active ingredient distributionVSAvoidprocess complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The dosage form is divided into multiple discrete volume increments (voxels) that can be independently designed and printed. Each voxel can contain different active ingredients, carrier materials, and concentrations, enabling flexible material selection and drug distribution patterns without requiring complex integrated manufacturing equipment

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the dosage form can have different properties by varying the composition, volume, and arrangement of individual voxels. This allows localized control over active ingredient distribution, release rates, and material properties throughout the dosage form structure

Inventive Principle:
Principle #3Local quality

2Manufacturing precision

If uniform volume increments are used in 3D printing, then manufacturing simplicity is maintained, but controlled release profiles and drug targeting capabilities are limited

Engineering Contradiction:
Improvecontrolled release profile precisionVSAvoidmanufacturing simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The volume of individual voxels is varied according to a specific gradient pattern (increasing from outside to inside) to control drug release kinetics. This parameter variation enables tailored release profiles and targeting capabilities while maintaining a relatively simple additive manufacturing process

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If complex dosage forms with varied active ingredient distribution are created, then drug targeting capability is improved, but manufacturing time and process complexity increase

Engineering Contradiction:
Improvedrug targeting capabilityVSAvoidmanufacturing speed
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The digital model of the dosage form is pre-designed with the desired active ingredient distribution and voxel volume gradients before manufacturing. This preliminary digital planning enables complex drug targeting patterns to be achieved through straightforward additive manufacturing, reducing actual production time

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the production of flexible, customizable pharmaceutical dosage forms and medical devices with controlled release profiles and drug targeting capabilities, enhancing the uniformity and specificity of active ingredient delivery.

Implementation Method 1

the volume increments comprise a base composition or base substance that is flowable at a printing temperature compatible with the at least one active ingredient, which solidifies after printing the respective volume increment

Methodology Applied
Scientific EffectMelting and Solidification: Melting

Implementation Method 2

the volume increments are superficially bonded to one another

Methodology Applied
Scientific EffectSuperficial bonding: Adhesive

Data Source

PatentEP3975986B1Additive method for 3D printing active ingredient-containing objects
Publication Date: 2026.04.08 DIHESYS DIGITAL HEALTH SYST GMBH
  • EP3975986B1 patent drawingFigure 1~2B
  • EP3975986B1 patent drawingFigure 3~5
  • EP3975986B1 patent drawingFigure 6~7

AI summary

The invention relates to an additive method for manufacturing solid or semi-solid two- or three-dimensional objects that contain one or more pharmaceutical active ingredients, and to objects obtained by said method, such as semi-solid or solid dosage forms or medical products. The method is a three-dimensional printing method by way of which individual defined volume increments are printed that can be substantially freely chosen in terms of the active ingredients contained, substrate materials used, shape, size, color, active ingredient concentrations and location in the manufactured object.